From Bench to Bedside

Coronary artery disease research group is devoted to study all aspects of coronary artery disease. We execute basic and translational research from pathogenesis and immunogenetics to epidemiology and clinical drug trials. Our aim is to discover basic mechanisms behind coronary artery disease, and to influence them so that major adverse events would diminish. Ongoing studies are based on large collected materials such as Corogene-study, ASO-material and the hearts’ explanted during transplantation. Epidemiological studies are based mainly on over ten years follow up data of Corogene-study. Clinical drug trials are located in Meilahti Hospital Heart and Lung Center. Pathogenesis, inflammation, immunogenetics studies are done in collaboration with Haartman-institute.
@JuhaSinisalo

Old method: dye dilution is used only in HUS thanks to M Ventilä. It is useful and working well pubmed.ncbi.nlm.nih.gov/33020256/

COVID-19 epidemia lowered effectively myocardial infarction cases pubmed.ncbi.nlm.nih.gov/32945201/

Krooninen sepelvaltimotauti voi paljastua hammaslääkärikäynnillä yle.fi/uutiset/3-1154… #uutisvahti

New Guideline in available. 2020 ESC Guidelines for the management of adult congenital heart disease. pubmed.ncbi.nlm.nih.gov/32860028/